Patents by Inventor Sophie Anne Michèle Bozonnet

Sophie Anne Michèle Bozonnet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions and dermatogic compositions synthesized from catalytic domains producing highly ?1,2 branched dextrans
    Patent number: 9957488
    Abstract: The invention relates to an isolated polypeptide with an glycosyl transferase enzymatic activity for producing dextrans with .alpha.(1.fwdarw.2) sidechains, comprising at least one region for bonding to glucan and a catalytically active region situated beyond the region bonding to glucan. The invention further relates to polynucleotides coding for said enzymes and vectors containing the same.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: May 1, 2018
    Assignee: INSITUT NATIONAL DES SCIENCES APPLIQUEES (INSA)
    Inventors: Sophie Anne Michèle Bozonnet, Magali Martine Claude Remaud-Simeon, René-Marc Lucien Willemot, Pierre Emmanuel Frédéric Monsan
  • Prebiotic composition or pharmaceutical composition synthesized from catalytic domains producing highly alpha-1,2 branched dextran
    Patent number: 9688968
    Abstract: The invention relates to an isolated polypeptide with an glycosyl transferase enzymatic activity for producing dextrans with .alpha.(1.fwdarw.2) sidechains, comprising at least one region for bonding to glucan and a catalytically active region situated beyond the region bonding to glucan. The invention further relates to polynucleotides coding for said enzymes and vectors containing the same.
    Type: Grant
    Filed: May 15, 2014
    Date of Patent: June 27, 2017
    Assignee: INSTITUT NATIONAL DES SCIENCES APPLIQUEES (INSA)
    Inventors: Sophie Anne Michèle Bozonnet, Magali Martine Claude Remaud-Simeon, René-Marc Lucien Willemot, Pierre Emmanuel Frédéric Monsan
  • Prebiotic composition or pharmaceutical composition synthesized from catalytic domains producing highly alpha-1,2 branched dextran
    Publication number: 20170152489
    Abstract: The invention relates to an isolated polypeptide with an glycosyl transferase enzymatic activity for producing dextrans with .alpha.(1.fwdarw.2) sidechains, comprising at least one region for bonding to glucan and a catalytically active region situated beyond the region bonding to glucan. The invention further relates to polynucleotides coding for said enzymes and vectors containing the same.
    Type: Application
    Filed: February 13, 2017
    Publication date: June 1, 2017
    Applicant: INSTITUT NATIONAL DES SCIENCES APPLIQUEES (INSA)
    Inventors: Sophie Anne Michèle BOZONNET, Magali Martine Claude REMAUD-SIMEON, René-Marc Lucien WILLEMOT, Pierre Emmanuel Frédéric MONSAN
  • PREBIOTIC COMPOSITION OR PHARMACEUTICAL COMPOSITION SYNTHESIZED FROM CATALYTIC DOMAINS PRODUCING HIGHLY ALPHA-1,2 BRANCHED DEXTRAN
    Publication number: 20150086525
    Abstract: The invention relates to an isolated polypeptide with an glycosyl transferase enzymatic activity for producing dextrans with .alpha.(1.fwdarw.2) sidechains, comprising at least one region for bonding to glucan and a catalytically active region situated beyond the region bonding to glucan. The invention further relates to polynucleotides coding for said enzymes and vectors containing the same.
    Type: Application
    Filed: May 15, 2014
    Publication date: March 26, 2015
    Inventors: Sophie Anne Michèle BOZONNET, Magali Martine Claude REMAUD-SIMEON, René-Marc Lucien WILLEMOT, Pierre Emmanuel Frédéric MONSAN
  • Prebiotic composition or pharmaceutical composition synthesized from catalytic domains producing highly ?-1,2 branched dextran
    Patent number: 8758744
    Abstract: The invention relates to an isolated polypeptide with an glycosyl transferase enzymatic activity for producing dextrans with .alpha.(1.fwdarw.2) sidechains, comprising at least one region for bonding to glucan and a catalytically active region situated beyond the region bonding to glucan. The invention further relates to polynucleotides coding for said enzymes and vectors containing the same.
    Type: Grant
    Filed: June 25, 2008
    Date of Patent: June 24, 2014
    Assignee: Institut National des Sciences Appliquees (INSA)
    Inventors: Sophie Anne Michèle Bozonnet, Magali Martine Claude Remaud-Simeon, René—Marc Lucien Willemot, Pierre Emmanuel Frédéric Monsan
  • Nucleic acid molecules coding for a dextransaccharase catalysing the synthesis of dextran with alpha 1,2 osidic sidechains
    Publication number: 20090123448
    Abstract: The invention relates to an isolated polypeptide with an glycosyl transferase enzymatic activity for producing dextrans with .alpha.(1.fwdarw.2) sidechains, comprising at least one region for bonding to glucan and a catalytically active region situated beyond the region bonding to glucan. The invention further relates to polynucleotides coding for said enzymes and vectors containing the same.
    Type: Application
    Filed: June 25, 2008
    Publication date: May 14, 2009
    Inventors: Sophie Anne Michele Bozonnet, Magali Martine Claude Remaud-Simeon, Rene-Marc Lucien Willemot, Pierre Emmanuel Frederic Monsan